All Terrain Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History

All Terrain Financial Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,000	Closed	-$101K	–	219
2019 Q3	$101K	Sell	2,000 -1,000	-33%	-$47K	0.03%	177
2019 Q2	$136K	Buy	3,000 +1,000	+50%	+$46.6K	0.05%	164
2019 Q1	$95K	Buy	2,000 +1,000	+100%	+$49.8K	0.03%	192
2018 Q4	$52K	Hold	1,000	–	–	0.02%	183
2018 Q3	$62K	Hold	1,000	–	–	0.03%	207
2018 Q2	$55K	Buy	+1,000	New	+$54K	0.02%	208

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

All Terrain Financial Advisors's BMY Position: Q1 2025 in Review

All Terrain Financial Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 5,606 shares — an estimated $317K sold.

All Terrain Financial Advisors first reported a position in BMY in Q4 2017 and held it in 29 quarters. The position peaked at $523K in Q2 2022. 2,476 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

All Terrain Financial Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
All Terrain Financial Advisors sold 5,606 Bristol-Myers Squibb shares in Q1 2025, an estimated $317K.
All Terrain Financial Advisors first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 29 quarters.
All Terrain Financial Advisors's Bristol-Myers Squibb position peaked at $523K in Q2 2022.
2,476 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on All Terrain Financial Advisors's 13F filing for Q1 2025, filed 15 May 2025.